Home

Immix Biopharma, Inc. - Common Stock (IMMX)

1.9400
-0.0300 (-1.52%)

Immix Biopharma, Inc. is a biotechnology company focused on developing innovative therapies for a range of medical conditions, particularly in the area of immuno-oncology

The company aims to harness the body's immune system to fight cancer and other diseases by creating advanced treatment options that target specific disease mechanisms. Immix Biopharma is dedicated to conducting rigorous research and clinical trials to bring novel therapeutic solutions from the lab to the market, ultimately improving patient outcomes and enhancing quality of life.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Immix Biopharma, Inc. - Common Stock publicly traded?
Yes, Immix Biopharma, Inc. - Common Stock is publicly traded.
What exchange does Immix Biopharma, Inc. - Common Stock trade on?
Immix Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immix Biopharma, Inc. - Common Stock?
The ticker symbol for Immix Biopharma, Inc. - Common Stock is IMMX on the Nasdaq Stock Market
What is the current price of Immix Biopharma, Inc. - Common Stock?
The current price of Immix Biopharma, Inc. - Common Stock is 1.940
When was Immix Biopharma, Inc. - Common Stock last traded?
The last trade of Immix Biopharma, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025